The cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index; 2 of the 10 sources its claims cite were checked for support.
Abstract
BACKGROUND: There is evidence that social anxiety disorder (SAD) is a prevalent and disabling disorder. However, most of the available data on the epidemiology of this condition originate from high income countries in the West. The World Mental Health (WMH) Survey Initiative provides an opportunity to investigate the prevalence, course, impairment, socio-demographic correlates, comorbidity, and treatment of this condition across a range of high, middle, and low income countries in different geographic regions of the world, and to address the question of whether differences in SAD merely reflect differences in threshold for diagnosis. METHODS: Data from 28 community surveys in the WMH Survey Initiative, with 142,405 respondents, were analyzed. We assessed the 30-day, 12-month, and lifetime prevalence of SAD, age of onset, and severity of role impairment associated with SAD, across countries. In addition, we investigated socio-demographic correlates of SAD, comorbidity of SAD with other mental disorders, and treatment of SAD in the combined sample. Cross-tabulations were used to calculate prevalence, impairment, comorbidity, and treatment. Survival analysis was used to estimate age of onset, and logistic regression and survival analyses were used to examine socio-demographic correlates. RESULTS: SAD 30-day, 12-month, and lifetime prevalence estimates are 1.3, 2.4, and 4.0% across all countries. SAD prevalence rates are lowest in low/lower-middle income countries and in the African and Eastern Mediterranean regions, and highest in high income countries and in the Americas and the Western Pacific regions. Age of onset is early across the globe, and persistence is highest in upper-middle income countries, Africa, and the Eastern Mediterranean. There are some differences in domains of severe role impairment by country income level and geographic region, but there are no significant differences across different income level and geographic region in the proportion of respondents with any severe role impairment. Also, across countries SAD is associated with specific socio-demographic features (younger age, female gender, unmarried status, lower education, and lower income) and with similar patterns of comorbidity. Treatment rates for those with any impairment are lowest in low/lower-middle income countries and highest in high income countries. CONCLUSIONS: While differences in SAD prevalence across countries are apparent, we found a number of consistent patterns across the globe, including early age of onset, persistence, impairment in multiple domains, as well as characteristic socio-demographic correlates and associated psychiatric comorbidities. In addition, while there are some differences in the patterns of impairment associated with SAD across the globe, key similarities suggest that the threshold for diagnosis is similar regardless of country income levels or geographic location. Taken together, these cross-national data emphasize the international clinical and public health significance of SAD.
Overview
CoChat Summary
## TL;DR
This WMH cross-national survey study found that social anxiety disorder (SAD) is common worldwide, with 4.0% lifetime, 2.4% 12-month, and 1.3% 30-day prevalence across all countries. Despite cross-national differences in prevalence, the paper reports consistent global patterns of early onset, persistence, impairment, socio-demographic correlates, comorbidity, and treatment access.
## Key findings
- Across all countries, SAD prevalence was 4.0% lifetime, 2.4% 12-month, and 1.3% 30-day.
- Average prevalence was highest in high-income countries (5.5% lifetime, 3.1% 12-month, 1.7% 30-day) and lowest in low/lower-middle-income countries (1.6%, 1.0%, 0.5%).
- Projected lifetime risk for SAD across the globe was 4.4%; the paper describes onset as early, with risk spanning from the mid-late adolescence to the early 40s.
- Among respondents with 12-month SAD, between one-third and one-half had severe role impairment in at least one domain; 38% of those with 12-month SAD received any treatment in the past 12 months, and treatment among those with any impairment ranged from 18.0% in low/lower-income countries to 44.2% in high-income countries.
## Methods
- Data came from 28 community surveys in the WMH Survey Initiative, totaling 142,405 respondents, spanning high-, upper-middle-, and low/lower-middle-income countries across multiple world regions.
- SAD was assessed with the WHO Composite International Diagnostic Interview (CIDI 3.0); impairment was measured with the Sheehan Disability Scale, and treatment use was assessed by self-report of contact with listed providers.
- Analyses used cross-tabulations for prevalence/impairment/comorbidity/treatment, survival analysis for age of onset and projected lifetime risk, and logistic regression and survival analyses for socio-demographic correlates; weighted clustered data were handled with Taylor series linearization.
## Limitations
- The paper states that response rates differed widely across surveys, and that some severe cases may have been less likely to participate, especially where treatment was less available.
- The surveys were not fully uniform: some were metropolitan-only or otherwise non-national, which the paper says may have affected prevalence estimates.
- The paper notes that the surveys excluded institutionalized patients and people too intoxicated to be interviewed, and that only two African countries were studied, limiting geographic comparisons.
- The text also makes evident that the SAD measure may under-detect culturally shaped presentations because the CIDI screening stem questions were limited and did not address fear of offending others; this is stated in the discussion as a measurement limitation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
2 Valid · 0 Not valid · 7 Not checked · 54 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As detailed elsewhere, good CIDI-SCID diagnostic concordance was found for SAD — area under the curve (AUC) = 0.67 — and most other DSM-IV/CIDI disorders [18].”
§ The cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative > Methods > Measures
What the sources say
- Partly supportedcites [18] Haro JM, Arbabzadeh-Bouchez S, Brugha TS, de Girolamo G, Guyer ME, Jin R, Lepine JP, Mazzi F, Reneses B, Vilagut G, Sampson NA, Kessler RC. Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. Int J Methods Psychiatr Res. 2006;15:167–80. sourceExperimental — accuracy not yet measured
The Abstract and the 'Lifetime individual-level concordance' section support the second half of the sentence — 'Moderate to good individual-level CIDI-SCID concordance was found for lifetime prevalence estimates of most disorders', with individual-disorder AUC in the range 0.62–0.93. However, for social anxiety/phobia the source explicitly places it in the weakest band: concordance is 'fair (AUC in the range 0.6–0.7) for the remaining disorders (specific phobia, social phobia, PTSD, drug dependence)' (Lifetime individual-level concordance). So an AUC of 0.67 is consistent with the reported range, but the source characterises SAD concordance as fair, not good — the citing sentence overstates that part. Our copy's retrievable Table 1 rows do not print the exact social phobia AUC value (only Adult ADHD 0.861 and Any disorder 0.76 appear), so the precise figure 0.67 could not be verified verbatim. (LLM, conf=0.82)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SAD recurrence is particularly highly associated with lower education (with no education having an odds ratio [OR] of 5.6, confidence interval [CI] 2.2–14.4)”
§ The cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative > Results > Socio-demographic correlates
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both cases around 80% of such respondents meet lifetime criteria for any other mental disorder.”
§ The cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative > Results > Comorbidity
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Across all countries, the risk period for onset of SAD ranges from the mid-late adolescence to the early 40s.”
§ The cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative > Results > Age of onset
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“with a mean number of days out of work of 24.7 (1.8) in the past year”
§ The cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative > Results > Impairment
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims
Create a free account to see all 63 claims and to verify the 8 references still open.
- Probably not a substantial claim. 6
- It may state two separate claims as one. 35
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SAD is estimated to have a lifetime prevalence of 5.5% in high-income countries and 3% in Western Europe (Stein et al., 2017)”
From Virtual Reality exposure therapy in the treatment of public speaking anxiety and social anxiety disorder (2024) · cites this paper as Stein et al., 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SAD has its most frequent onset during adolescence (i.e., before the age of 18) [4,5,6].”
From The Prevalence of Adolescent Social Fears and Social Anxiety Disorder in School Contexts (2022) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both these disorders tend to reveal a chronic course that may fluctuate by evolving into other ADs or mood disorders in adulthood [21, 68, 69].”
From Acceptance and commitment therapy as a transdiagnostic approach to adolescents with different anxiety disorders: study protocol. (2025) · cites this paper as [69]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Difficulties associated with SAD usually start in adolescence (Stein et al., 2017; Knappe et al., 2015)”
From Psychological inflexibility explains social anxiety over time: a mediation analyses with a clinical adolescent sample (2024) · cites this paper as Stein et al., 2017
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Accumulating evidence from preclinical studies suggests that activation of α7-nAChR signalling results in suppression or prevention of anxiety. 20–22”
From Efficacy and safety of an alpha 7-nicotinic acetylcholine receptor agonist, VQW-765, in subjects with performance anxiety: randomised, double-blind, placebo-controlled trial (2025) · cites this paper as [20]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Kessler, R. C., & Üstün, T. B. (2004) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.168 · Cited by 4,771 · cited 1×
“0) [15], a fully structured lay-administered interview.”
Self-citationSheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440
Introduction to Variance Estimation.
King, B. F., & Wolter, K. M. (1987) · Journal of the American Statistical Association · doi:10.2307/2289497 · Cited by 1,377
Haro, J. M., Arbabzadeh-Bouchez, S., Brugha, T. S., De Girolamo, G., Guyer, M. E., Jin, R., Lepine, J. P., Mazzi, F., Reneses, B., Vilagut, G., et al. (2006) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.196 · Cited by 1,082
Self-citationAgoraphobia, simple phobia, and social phobia in the National Comorbidity Survey
Magee, W. J. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830020077009 · Cited by 996
Self-citationThe WHO World Mental Health Surveys: Global Perspectives on the Epidemiology of Mental Disorders
Kessler, R. C., & Üstün, T. B. (2008) · Cited by 872
Self-citationSocial fears and social phobia in the USA: results from the National Comorbidity survey replication
Ruscio, A. M., Brown, T. A., Chiu, W. T., Sareen, J., Stein, M. B., & Kessler, R. C. (2008) · Psychological Medicine · doi:10.1017/s0033291707001699 · Cited by 835
Self-citationIntroduction to Variance Estimation
Hidiroglou, M. A. (1986) · Technometrics · doi:10.1080/00401706.1986.10488138 · Cited by 820
Mini-SPIN: A brief screening assessment for generalized social anxiety disorder
Connor, K. M., Kobak, K. A., Churchill, L. E., Katzelnick, D., & Davidson, J. R. T. (2001) · Depression and Anxiety · doi:10.1002/da.1055 · Cited by 537 · cited 1×
“Research in clinical settings has also indicated that SAD is a prevalent and disabling condition in this context [5, 6].”
BackgroundEpidemiology of Anxiety Disorders
Kessler, R. C., Ruscio, A. M., Shear, K., & Wittchen, H.-U. (2009) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2009_9 · Cited by 496
Self-citation
Research works printed but not linked: 4
- Kessler R, Ustun T. The WHO World Mental Health Surveys: global perspectives on the epidemiology of mental disorders. New York: Cambridge University Press; 2008.
- Pennell B-E, Mneimneh Z, Bowers A, Chardoul S, Welles J, Viana M, Dinkelmann K, Gebler N, Florescu S, He Y, Huang Y, Tomov T, Vilagut G. Implementation of the World Mental Health Surveys Initiative. In: Kessler R, Ustun T, editors. The WHO World Mental Health Surveys: global perspectives on the epidemiology of mental disorders. New York: Cambridge University Press; 2008. p. 33–57.
- First MB, Spitzer RL, Gibbon M, Williams BJ. Structured Clinical Interview for Axis I DSM-IV Disorders. New York: Biometrics Research, New York State Psychiatric Institute; 1994.
- Institute RT. SUDAAN: Professional Software for Survey Data Analysis. Research Triangle Park: Research Triangle Institute; 2002.
Cited by
Shi, L., Lu, Z.-A., Que, J.-Y., Huang, X.-L., Liu, L., Ran, M.-S., Gong, Y.-M., Yuan, K., Yan, W., Sun, Y.-K., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.14053 · Cited by 804
Quantifying the global burden of mental disorders and their economic value
Arias, D., Saxena, S., & Verguet, S. (2022) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101675 · Cited by 771
Penninx, B. W., Pine, D. S., Holmes, E. A., & Reif, A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00359-7 · Cited by 740
Epidemiology of anxiety disorders: global burden and sociodemographic associations
Javaid, S. F., Hashim, I. J., Hashim, M. J., Stip, E., Samad, M. A., & Ahbabi, A. A. (2023) · Middle East Current Psychiatry · doi:10.1186/s43045-023-00315-3 · Cited by 426
Sex differences in the developing brain: insights from multimodal neuroimaging
Kaczkurkin, A. N., Raznahan, A., & Satterthwaite, T. D. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0111-z · Cited by 403
Metadata
- Authors
- Collaborators, W. W. M. H. S., Stein, D. J., Lim, C. C. W., Roest, A. M., de Jonge, P., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., Benjet, C., Bromet, E. J., Bruffaerts, R., de Girolamo, G., Florescu, S., Gureje, O., Haro, J. M., Harris, M. G., He, Y., Hinkov, H., Horiguchi, I., Hu, C., Karam, A., Karam, E. G., Lee, S., Lepine, J.-P., Navarro-Mateu, F., Pennell, B.-E., Piazza, M., Posada-Villa, J., ten Have, M., Torres, Y., Viana, M. C., Wojtyniak, B., Xavier, M., Kessler, R. C., & Scott, K. M.
- Affiliations
- University of Cape Town (ZA)
- University Medical Center Groningen (NL)
- University of Al-Qadisiyah (IQ)
- Universitat Pompeu Fabra (ES)
- Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz (MX)
- Stony Brook University (US)
- Centro San Giovanni di Dio Fatebenefratelli (IT)
- University College Hospital, Ibadan (NG)
- The University of Queensland (AU)
- Shanghai Mental Health Center (CN)
- National Center of Public Health and Analyses (BG)
- Shenzhen KangNing Hospital (CN)
- University of Balamand (LB)
- Inserm (FR)
- Universidad Peruana Cayetano Heredia (PE)
- Universidad CES (CO)
- Narodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy (PL)
- Harvard University (US)
- University of Otago (NZ)
- Corresponding author
- Stein, Dan J.
- ORCID
- Venue
- BMC Medicine
- Published
- 2017-07-31
- Volume
- 15
- Issue
- 1
- Pages
- 143-143
- ISSN
- 1741-7015 (ISSN-L)
- PMC
- PMC5535284
- OpenAlex
- W2741980530
- Cited by
- 520
- References
- 26
- Citations by year
- 2026: 59 · 2025: 86 · 2024: 91 · 2023: 74 · 2022: 51 · 2021: 74 · 2020: 39 · 2019: 33 · 2018: 11 · 2017: 1
- FWCI
- 29.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- BMC Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (publishedVersion, other-oa)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Open University of Cape Town (University of Cape Town) (submittedVersion, cc-by)
- Open University of Cape Town (University of Cape Town) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, cc-by)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Greater South Information System
- Funders
- National Institute of Mental Health (R01 MH070884)
- John D. and Catherine T. MacArthur Foundation
- Pfizer Foundation
- U.S. Public Health Service (R13-MH066849, R01-MH069864, R01 DA016558)
- Fogarty International Center (FIRCA R03-TW006481)
- Pan American Health Organization
- Eli Lilly and Company
- Ortho-McNeil Pharmaceutical Inc.
- GlaxoSmithKline
- Bristol-Myers Squibb
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Keywords
- social anxiety disorder, prevalence, age of onset, role impairment, psychiatric comorbidity, treatment rates, sociodemographic correlates, income level, geographic region, diagnostic thresholds, World Mental Health Survey Initiative, low- and middle-income countries, gender differences, education and income, disability burden, access to mental health care
- MeSH terms
- Phobia, Social, Adolescent, Adult, Africa, Aged, Child, Child, Preschool, Female, Health Surveys, Humans, Income, Male, Middle Aged, Global Health, Comorbidity, Prevalence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative. https://app.cochat.ai/papers/10.1186/s12916-017-0889-2
- The paper
- Collaborators, W. W. M. H. S., Stein, D. J., Lim, C. C. W., Roest, A. M., de Jonge, P., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., Benjet, C., Bromet, E. J., Bruffaerts, R., de Girolamo, G., Florescu, S., Gureje, O., Haro, J. M., Harris, M. G., He, Y., Hinkov, H., Horiguchi, I., . . . Scott, K. M. (2017). The cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative. BMC Medicine. https://doi.org/10.1186/s12916-017-0889-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
